細胞・遺伝子治療における化学・製造・管理(CMC)のための相関分析の応用
Sangwook Choi1, Alan Y Chiang2, Catherine Cheng3
1Biostatistics, Cell Therapy Development and Operations, Bristol Myers Squibb, Seattle, WA, USA.
Abstract:
Correlative analysis is widely used in drug product development and manufacturing to explore the potential associations between attributes of interest. The manufacturing and control of cell and gene therapy (CGT) products are often affected by multiple factors, such as limited knowledge of product characteristics, variable starting materials, complex manufacturing and limited manufacturing experience. Understanding of correlations among process, product and clinical outcome parameters can support process optimization and improve product quality. In this paper, we review the applications of correlative analysis and discuss their implications in CGT product development and manufacturing. We also discuss the unique challenges associated with performing correlative analysis in CGT. Finally, we provide a summary of statistical techniques commonly used to identify associations among attributes related to Chemistry, Manufacturing and Controls (CMC) and clinical outcome. This review aims to provide insights into the effective use of correlative analysis to enhance the development and manufacturing of CGT products.
関連する概念動画
Drug Product Performance: In Vitro–In Vivo Correlation
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Therapeutic Drug Monitoring: Drug Analysis Methods
Cell Lines
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Analysis of Population Pharmacokinetic Data


